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Somatic Hypermutation, Minireview
Transcription, and DNA
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hypermutation, suggesting that cis-acting sequences
outside themutable region regulate and target mutation.
However, almost nothing is known about the detailed
molecular mechanisms or trans-acting proteins that are
responsible for V-region hypermutation.
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Because the mutational process begins just down-
stream of the promoter and requires transcriptional en-
hancers (Neuberger et al., 1998), it has been suggestedAntibody diversity is generated through geneticand mo-
that the initiation of transcription, or mutator moleculeslecular mechanisms that create a large repertoire of B
that are specifically recruited by the transcriptional ap-cells, each expressing an antibody with a different anti-
paratus, carry out error-prone repair at sites where thegen-binding site (Weill and Reynaud, 1996). This ensures
RNA polymerase pauses (Neuberger et al., 1998; Storbthat there will be B cells able to produce antibodies that
et al., 1998). A role for transcription, or at least for acces-will protect us from every possible pathogen. Diversity
sibility, was confirmed by Peters and Storb, when theyis initially generated by assembling various combina-
placed the L chain promoter and 59 flank just upstream,tions of germline V, D, and J genetic elements to form
and the intronic enhancer downstream of the L-chainheavy (H) and light (L) chain variable (V) regions that
constant region, and showed that the C region was thenencode many different antigen-binding sites. Progenitor
targeted for mutation (Peters and Storb, 1996). The re-B cells expressing these antigen receptors then migrate
cent Immunity paper by Fukita et al. (1998) reports afrom the adult bone marrow to the peripheral lymphoid
well-controlled series of experiments that confirms aorgans, where they interact with T cells and antigen-
role for transcription. They generated transgenic micepresenting cells and multiply in germinal centers. The
with targeted insertions in the H-chain locus to compareimmunoglobulin (Ig) genes in the germinal center B
transgenes that have a normal RNA polymerase II (polcells undergo further diversification through: (1) isotype
II) Ig promoter with transgenes lacking the H-chain pro-switching, in which the H-chain V region rearranges
moter or driven by a pol I promoter. These transgenesdown the locus to be expressed with one of the constant
were not expressed as proteins because they contained(C) region genes that encode the IgG, IgE, and IgA ef-
nonsense mutations and were therefore not subjected to
fector functions; and (2) somatic V-region hypermuta-
selection. The crucial observation was that the transgene
tion, resulting in amino acid substitutions that modulate
lacking a promoter accumulated 15-fold fewer muta-
the affinity and specificity of the antigen-binding sites tions than the transgene with the normal pol II promoter.
(MacLennan et al., 1997). B cells producing surface Ig Single-cell PCR was used to show that the endogenous
receptors that do not react with self components and light chains from the same cells underwent normal fre-
have higher affinity for antigen are selected for further quencies of mutation. The decrease in mutation of the
differentiation and expansion (reviewed by Kelsoe, 1996). transgene correlated with a decrease in the levels of
Characteristics of Somatic Hypermutation pre-mRNA, confirming a correlation between transcrip-
A large database of mutated antibody sequences and tion and mutation (Neuberger et al., 1998). Although
many molecular and transgenic studies have resulted there was a slightly lower frequency of mutation in the
in the following generally accepted, although perhaps transgene driven by the pol I promoter, the mutational
incorrect, descriptions of V-region hypermutation. First, spectrum was unchanged and the transgene transcripts
mutations result from nontemplated single base changes were polyadenylated, suggesting that pol II±like tran-
in rearranged H- and L-chain V-region genes and occur scripts were being generated. This confirms the findings
at rates of 1024±1023/base pair/generation, at least a that non-Ig promoters can mediate mutation (Neuberger
million-fold higher than the rate of mutation of most et al., 1998; Tumas-Brundage et al., 1996) and raises
other genes in mammalian cells. Second, the mutational the possibility that non-Ig genes might undergo hyper-
mutation in germinal center B cells. This appears to beprocess begins just downstream from the promoter and
true, since BCL-6, which is highly expressed in germinalends 1±2 kb further downstream. Third, the activation
center B cells, has recently been shown to accumulateof V-region mutation generally requires T-cell help and
large numbers of mutations in normal B cells with ais restricted to a brief period in B-cell development.
pattern similar to that seen in Ig genes (Shen et al.,Fourth, mutations appear more frequently in hot spot
1998). The lack of restriction of mutation to Ig genes ismotifs such as RGYW (A/G, G, C/T, A/T), result in transi-
a surprising finding, and it will no doubt take some timetions more often than transversions, and are less likely
to sort out its implications.to affect T than G, C, or A. It was initially thought that
Because transcription appears to play a role inthere was strand bias, but more recent analyses call
V-region hypermutation, components of the basal tran-this into question (Dorner et al., 1998) and suggest that
scriptional apparatus such as TFIIH, which also partici-at least part of the process is strand-independent
pates in nucleotide excision repair, have been studied.(Milstein et al., 1998). Lastly, foreign sequences can be
Hypermutation appears to proceed normally in mice andsubstituted for V(D)J and still serve as the targets for
humans with genetic defects in nucleotide and base
excision repair and in the repair of single- and double-
stranded DNA breaks (Wagner et al., 1996; Kim et al.,*To whom correspondence should be addressed.
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1997; Shen et al., 1997; Jacobs et al., 1998; Winter et
al., 1998). Although it is possible that the loss of a single
protein could be compensated for by other components
of a larger complex, these experiments suggest none of
these processes are responsible for V-region mutation.
The DNA Mismatch Repair System
The repair systems mentioned above are concerned
with the repair of damaged DNA. In contrast, misincor-
porated bases are repaired by the postreplicative DNA
mismatch repair (MMR) system. Since errors are rou-
tinely introduced during DNA replication,several studies
have recently focused on whether the proteins that nor-
mally repair the resulting mismatched bases are in-
volved in generating the initial V-region mutations, in
fixing them in the DNA, or in subsequently modulating
the outcome of the mutational process. In a recent issue
of Immunity, Frey et al. (1998) examine V-region hyper-
mutation in mice that are genetically defective in MSH2
or PMS2, two proteins that are components of the MMR
system. In the same issue, Rada et al. (1998) also exam-
ine V-region mutation in MSH2-defective mice.
The MMR system is remarkably conserved and many
of its basic features are shared between the E. coli
MutHLS system (Modrich, 1991) and eukaryotic MMR,
except that the latter is more complex (Kolodner, 1996).
In eukaryotes, the initiation of the repair process is
thought to require subsets of at least three different E.
coli MutS homologs: MSH2, MSH3, and MSH6. Studies
in yeast and mammalian cells have indicated that MMR
is initiated by two different complexes: an MSH2-MSH6
complex that recognizes single base mismatches, inser-
tions and deletions and an MSH2-MSH3 complex that
recognizes two to four base pair insertions and deletions
(Figure 1). However, the recognition of the different
classes of mismatches is not stringent and both com-
plexes share overlapping repair activities. In mam-
malian cells, the subsequent removal of the mismatched
base(s) is similar to the bacterial system and relies on
a complex between two MutL homologs, MLH1 and
PMS2, that interact with MSH2 (Figure 1). Much less
is known about subsequent steps in the pathway. A
mammalian homolog of the E. coli MutH endonuclease,
Figure 1. Proposed Model for Somatic Hypermutationwhich introduces nicks into the newly synthesized DNA
strand and thus directs repair, has not been identified. When the Ig gene is transcribed, an accessibility factor (A) allows
a putative mutator factor (M) to generate base mismatches, picturedIt is unclear how the mammalian MMR system distin-
as yellow triangles. These base mismatches are shown occurringguishes the parental from the newly synthesized DNA
on both strands, but this issue has yet to be fully resolved. In astrand. Recently, the proliferating cellular nuclear anti-
subsequent step, the MMR complex assembles and repairs some
gen (PCNA) has been shown to associate with MLH1, of the mismatches. In the next round of DNA replication, these
and possibly MSH2, a finding that may link MMR with mutations will be fixed into the genome. This model draws upon
replication and transcription-coupled nucleotide exci- various aspects of the proposals of Kolodner, Storb, Neuberger and
Milstein, and their colleagues (Kolodner, 1996; Neuberger et al.,sion repair (Mellon et al., 1996; Umar et al., 1996).
1998; Storb et al., 1998).The Mismatch Repair System
and Somatic Hypermutation
Frey et al. (1998) confirmed the findings of others (Ja-
They also observed in MSH2-deficient mice that acobs et al., 1998; Phung et al., 1998) that the frequency
greater percent of the mutations occurred within hotof V-region mutation in splenic germinal center cells
spot motifs in Peyer's patch germinal center cells. Radafrom MSH2-deficient mice was the same as in wild-type
et al. (1998) found more mutations in G/C than in A/T,controls. However, when Frey et al. (1998) and Rada
and this was also reported by Phung et al. (1998). Aet al. (1998) independently examined Peyer's patch
major issue is whether the different spectra of mutationsgerminal center cells from MSH2-deficient mice, they
seen in the MMR-deficient mice are due to inherentobserved a significant reduction in the frequency of
changes in the primary process of mutation, or to subse-V-region mutation. Both groups agree that those V re-
gions that are mutating accumulate fewer base changes. quent events including repair or changes in the cellular
Minireview
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dynamics of the immune response. The latter explana- mutations than control mice. They postulate that mis-
tion is favored by Frey et al. (1998) who observed a matches created by a change in two adjoining bases
much higher frequency of microsatellite instability, a are more readily recognized and repaired than single
hallmark of the mutator phenotype, in Peyer's patch base changes. Biochemical experiments with extracts
germinal center B cells than in the equivalent splenic from PMS2-deficient mice support this idea (Winter et
cells. They suggest that increased genome-wide DNA al., 1998). However, it is not clear why excessive dou-
alterations, as indicated by the very high microsatellite blets have not been observed by others who have stud-
instability in the chronically stimulated, rapidly dividing ied these mice.
Peyer's patch cells, may affect B-cell viability and limit In an attempt to define further the mechanism of the
their opportunity to recycle through germinal centers primary mutational event and the impact of subsequent
and accumulate additional V-region mutations. They mismatch repair, Bertocci et al. (1998) in the current
conclude that MSH2 is not participating directly in the issue of Immunity have examined the mutation of Ig
generation of V-region mutations. This was also the con- transgenes into which they have inserted mono- or dinu-
clusion from earlier work by others (Jacobs et al., 1998; cleotide repeats. They report that in normal mice, slip-
Phung et al., 1998). page events that might have been expected to occur in
Rada et al. (1998) also obtained evidence for a de- these tracts of repeats during DNA replication are rare,
crease in the maturation of the B-cell response in MSH2- compared with the frequency of point mutations in the
deficient mice and agreed that this, in part, could explain coding portion of the V regions. In mice that are deficient
the decreased frequency of mutations in Peyer's patch in MSH2 or PMS2, the frequency of V-region mutations
B cells. However, the increased focus on hot spots and in the germinal center B cells decreases. However, there
predominance of mutations in G/C led them to postulate is no increase in the absolute number of deletions or
two phases of the mutational process: an initial MSH2- insertions, suggesting that V-region mutation does not
independent phase that focuses the mutational process occur during scheduled DNA replication. This has led
on the hot spots, and a second MSH2-dependent phase Bertocci et al. (1998) to speculate that the primary muta-
that results in a wider distribution and range of muta- tional process is the result of a still undefined ªshort
tions. Based on the same observations, Phung et al. patch error-prone DNA synthesis.º
(1998) concluded that MSH2 normally repairs many of Conclusions
the G/C mutations, so the numbers of G/C and A/T The data presented in these four recent papers in Immu-
mutations are relatively the same once the process is nity (Bertocci et al., 1998; Frey et al., 1998; Fukita et
completed. In mice lacking MSH2, repair of the G/C al., 1998; Rada et al., 1998) implicate transcription or
mutations does not occur, resulting in an excess of G/C accessibility in V-region hypermutation and suggest that
mutations. It is interesting that Kuo et al. (1997) found MMR plays a role in secondary events that repair or
that mice that overexpress BCL-2 in their germinal cen- suppress certain types of mutations resulting from the
ter B cells do not target mutations to hot spot motifs, primary process of hypermutation, and thus alters the
again suggesting that the accumulation of mutations in spectrum of mutations observed in normal cells. Sec-
hot spots is the result of a multifaceted process. ondary modulations actually appear to be different in
PMS2 acts downstream of MSH2 (Figure 1) and its MSH2 and PMS2-deficient mice, as indicated by the
loss could have a different effect on the frequency or presence of distinct patterns of mutation. Since the pro-
characteristics of V-region mutations. While Frey et al. teins involved in MMR function as complexes, it will be
(1998) and Winter et al. (1998) did not detect a significant interesting to analyze the mutation spectra of mice that
difference in the frequency of mutations in germinal cen- are deficient in MSH3 and/or MSH6, the partners of
ter B cells from the spleens of PMS2-deficient mice,
MSH2 in mitotic MMR (Figure 1).
there was a decrease in mutation in the Peyer's patch
Based on the data presented in these recent Immunity
B cells of such mice. Cascalho et al. (1998) had reported
papers (Bertocci et al., 1998; Frey et al., 1998; Fukita et
an even greater decrease in the frequency of V-region
al., 1998; Rada et al., 1998), one could envision themutation in mice with PMS2-deficiency, which led them
model shown in Figure 1: (1) The chromatin structure ofto propose that PMS2 plays a direct role in the V-region
the transcribed but nonmutating Ig genes is altered/mutational process. Some of this discrepancy can be
opened as the result of some process of chromatin me-explained by differences in the method of calculating
tabolism (Wade et al., 1997). (2) This makes DNA acces-mutation frequency. In addition, the mice used by Cas-
sible to a DNA mutator factor/complex that introducescalho et al. (1998) express a single Ig transgene, and
mutated nucleotides (Neuberger et al., 1998; Storb etcirculating B cells were analyzed rather than germinal
al., 1998). (3) Some of these mismatched bases are rec-center B cells. The findings of Frey et al. (1998) provide
ognized by MMR and repaired. There might be a prefer-a rationalization for the conflicting data, since they show
ence for the repair of certain mismatches (e.g., G/Cs atthat similar B-cell populations that have undergone dif-
hot spots) while others are less efficiently repaired. Also,ferent degrees of stimulation have different frequencies
if there is an abundance of mutations, MMR may notof V-region mutation. This raises the possibility that the
be able to repair all of them, leaving some mutationscirculating B cells analyzed by Cascalho et al. (1998)
unrepaired. It is still unclear whether transcription ismay not be representative of the germinal center B cells
required for mutation or is a manifestation of accessibil-examined in the other studies. It is also possible that
ity (Sleckman et al., 1996). If in fact both strands of DNAstrain differences and ªmodifierº genes contribute to
are subject to the primary mutational event, it is lessthe different results. Winter et al. (1998) also found that
PMS2-deficient mice have a higher frequency of doublet likely that transcription per se is involved. It is possible
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Wade, P.A., Pruss, D., and Wolffe, A.P. (1997). Trends Biochem. Sci.that accessibility or transcription factors allow the re-
22, 128±132.cruitment of complexes that lead to the primary muta-
Wagner, S.D., Elvin, J.G., Norris, P., McGregor, J.M., and Neuberger,tional event. These considerations are still speculative
M.S. (1996). Int. Immunol. 8, 701±705.and additional experimentation, using larger numbers
Weill, J.-C., and Reynaud, C.A. (1996). Immunol. Today 17, 92±97.of transgenic and genetically defective mice and some
Winter, D.B., Phung, Q.H., Umar, A., Baker, S.M., Tarone, R.E., Ta-of the newer in vitro systems (reviewed by Green et
naka, K., Liskay, R.M., Kunkel, T.A., Bohr, V.A., and Gearhart, P.J.al., 1998), will be required to resolve the differences in
(1998). Proc. Natl. Acad. Sci. USA 95, 6953±6958.
results in the existing studies. Nevertheless, the studies
with mice defective in MMR have alerted us to the possi-
bility that we may not yet know the characteristics of
the products of the primary mutational event. They re-
mind us that in order to identify the biochemical mecha-
nisms, the challenge will be to uncouple the primary
mutational events from subsequent repair and to identify
the components of the protein complexes that are re-
sponsible for these processes.
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